J. Thome

发表

Modern neuroimaging in psychiatry: Towards the integration of functional and molecular information

D. Linden, J. Thome, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Resting state fMRI entropy probes complexity of brain activity in adults with ADHD

D. Linden, J. Thome, M. O. Sokunbi, 2013, Psychiatry Research: Neuroimaging.

Current source density analysis of resting state EEG in depression: a review

J. Thome, P. C. Koo, C. Berger, 2017, Journal of Neural Transmission.

Dysbindin-1 genotype effects on emotional working memory

J. Thome, D. Linden, C. Wolf, 2009, Molecular Psychiatry.

Driving and attention deficit hyperactivity disorder

D. de Waard, K. Brookhuis, J. Thome, 2015, Journal of Neural Transmission.

Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD

A. Ehlis, A. Fallgatter, J. Thome, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Brain Activity Supporting Working Memory Accuracy in Patients with Paranoid Schizophrenia: A Functional Magnetic Resonance Imaging Study

J. Thome, D. Linden, C. Wolf, 2011, Neuropsychobiology.

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

E Sobanski, S Kasper, R. Delorme, 2018, European Psychiatry.

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses

Robert Zöchling, Peter Riederer, J. Thome, 2001, Schizophrenia Research.

Regulation of cocaine reward by CREB.

N. Hiroi, E. Nestler, J. Thome, 1998, Science.

Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson’s disease

Gesine L. Alders, J. Thome, K. Lange, 2006, Journal of Neural Transmission.

The Circadian System in Alzheimer’s Disease: Disturbances, Mechanisms, and Opportunities

Bernhard T. Baune, Andrew N. Coogan, Peter Kropp, 2013, Biological Psychiatry.

Fluoxetine treatment induces EAAT2 expression in rat brain

J. Thome, P. Gebicke-haerter, M. Zink, 2011, Journal of Neural Transmission.

Elevated oleic acid serum concentrations in patients suffering from alcohol dependence

J. Thome, A. Büttner, G. Irmisch, 2013, Journal of molecular psychiatry.

Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression

R. Buchert, H. Hampel, J. Thome, 2011, Progress in Neurobiology.

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

J. Gewirtz, J. Thome, R. Duman, 1999, Neuroscience Letters.

Stress differentially regulates synaptophysin and synaptotagmin expression in hippocampus

J. Gewirtz, J. Thome, R. Duman, 2001, Biological Psychiatry.

The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in mice

J. Thome, A. Coogan, S. O'Keeffe, 2012, Neuroscience.

Profiling for novel proteomics biomarkers in neurodevelopmental disorders

J. Thome, E. Dudley, F. Hässler, 2011, Expert review of proteomics.

Relations of EEG-brain mapping and HMPAO-SPECT with the severity of Alzheimer's dementia (DAT)

W. Strik, T. Dierks, J. Thome, 1997, Psychiatry Research: Neuroimaging.

The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry

J. Thome, F. Faltraco, Frederick Simon, 2021, International journal of environmental research and public health.

Proteomic research in psychiatry

J. Thome, M. Gerlach, A. Warnke, 2011, Journal of psychopharmacology.

Potential genetic markers of sporadic Alzheimer's dementia

J. Thome, J. Kornhuber, P. Riederer, 2001, Psychiatric genetics.

Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies

C. Parsons, J. Thome, J. Kornhuber, 2005, Journal of Neural Transmission / General Section JNT.

University of Groningen Driving and attention deficit hyperactivity disorder

D. de Waard, K. Brookhuis, J. Thome, 2015 .

Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome

J. Thome, J. Kornhuber, P. Riederer, 1995, Journal of neural transmission. Parkinson's disease and dementia section.

ZNF804A Genotype Modulates Neural Activity during Working Memory for Faces

S. Johnston, J. Thome, D. Linden, 2013, Neuropsychobiology.

Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene

S. Johnston, J. Thome, D. Linden, 2011, European Neuropsychopharmacology.

Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder

J. Thome, P. Wender, M. Schneider, 2004, European Archives of Psychiatry and Clinical Neuroscience.

Inflammation: good or bad for ADHD?

J. Thome, R. Donev, 2010, Attention deficit and hyperactivity disorders.

Neurochemical investigations in patients with dementia of Alzheimer type and their clinical value

K. Lesch, R. Ihl, T. Dierks, 1994 .

Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.

J. Thome, J. Kornhuber, P. Riederer, 1996, Life sciences.

Attention deficit hyperactivity disorder (ADHD) in a 19th century children’s book

K. A. Jacobs, J. Thome, 2004, European Psychiatry.

Polypharmacy in the treatment of subjects with intellectual disability

J. Thome, O. Reis, Frank Häβler, 2015, Journal of Neural Transmission.

ADHD and offenders

J. Thome, S. Young, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study.

J. Thome, M. Deuschle, G. Paslakis, 2012, Pharmacopsychiatry.

Neurotrophin levels at admission did not change significantly upon alcohol deprivation and were positively correlated with the BMI and LDL levels

J. Thome, G. Irmisch, A. Popa-Wagner, 2013, Journal of molecular psychiatry.

Increased concentrations of manganese superoxide dismutase in serum of alcohol-dependent patients.

J. Thome, P. Riederer, P. Foley, 1997, Alcohol and alcoholism.

Growth hormone response to placebo, apomorphine and growth hormone releasing hormone in abstinent alcoholics and control subjects.

J. Thome, T. Mueller, T. Kraus, 1998, Drug and alcohol dependence.

Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus

J. Thome, P. Gebicke-haerter, M. Zink, 2005, Psychopharmacology.

The current status of research into attention deficit hyperactivity disorder: proceedings of the 2nd international congress on ADHD: from childhood to adult disease

J. Thome, D. P. Reddy, 2009, Attention deficit and hyperactivity disorders.

Homozygosity at the dopamine D3 receptor gene in schizophrenic patients

J. Thome, P. Riederer, P. Foley, 1996, Neuroscience Letters.

The role of sleep problems and circadian clock genes in attention-deficit hyperactivity disorder and mood disorders during childhood and adolescence: an update

J. Thome, S. Cohrs, C. Berger, 2017, Journal of Neural Transmission.

ADHD matures: time for practitioners to do the same?

D. Nutt, J. Thome, U. Müller, 2012, Journal of psychopharmacology.

Handbook for attention deficit hyperactivity disorder in adults

J. Thome, U. Müller, G. Gudjonsson, 2013 .

An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder

J. Thome, 2008, Evidence-Based Mental Health.

Neurotrophic factor‐related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high‐risk male population

R. M. Clement, C. Freitag, J. Thome, 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Clock Genes Profiles as Diagnostic Tool in (Childhood) ADHD—A Pilot Study

J. Thome, M. Kölch, H. Oster, 2022, Brain sciences.

CNTF and endogenous psychoses?

J. Thome, J. Kornhuber, P. Riederer, 1996, Nature Genetics.

Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased of psychiatric diseases?

J. Thome, J. Kornhuber, P. Riederer, 1996, Neuroscience Letters.

Association between a null mutation in the human ciliary neurotrophic factor (CNTF) gene and increased incidence of psychiatric diseases?

J. Thome, J. Kornhuber, P. Riederer, 1996, Neuroscience letters.

Challenges for mental health services during the 2020 COVID‐19 outbreak in Germany

J. Thome, F. Faltraco, O. Tucha, 2020, Psychiatry and Clinical Neurosciences.

Neural plasticity to stress and antidepressant treatment

J. Thome, R. Duman, J. Malberg, 1999, Biological Psychiatry.

Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products.

J. Thome, P. Riederer, M. Gerlach, 1997, Alcoholism, clinical and experimental research.

Age and Time of Day Influences on the Expression of Transforming Growth Factor-Beta and Phosphorylated SMAD3 in the Mouse Suprachiasmatic and Paraventricular Nuclei

J. Thome, A. Coogan, A. L. Beynon, 2009, Neuroimmunomodulation.

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

K. Jellinger, L. Iversen, K. Lesch, 1995, Journal of Neural Transmission / General Section JNT.

The effects of GABA transporter inhibition on synaptophysin and synaptotagmin expression in diazepam tolerance

J. Thome, C. Jennen-Steinmetz, A. Coogan, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The effects of GABA transporter inhibition on synaptophysin and synaptotagmin expression in diazepam tolerance.

J. Thome, C. Jennen-Steinmetz, A. Coogan, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease.

T. Dierks, A. Fallgatter, W. Strik, 1997, European archives of psychiatry and clinical neuroscience.

Vitamin D and its relation to sleep disturbance and depressive symptomatology – Results of the German Health Interview and examination survey for adults

J. Thome, S. Cohrs, M. Goerke, 2015 .

Therapeutic Drug Monitoring of Zuclopenthixol in a Double-Blind Placebo-Controlled Discontinuation Study in Adults with Intellectual Disabilities and Aggressive Behaviour

J. Thome, C. Hiemke, O. Reis, 2013, Pharmacopsychiatry.

COVID-19 paranoia in a patient suffering from schizophrenic psychosis – a case report

J. Thome, F. Faltraco, A. Coogan, 2020, Psychiatry Research.

The role of sleep problems and circadian clock genes in childhood psychiatric disorders

J. Thome, F. Haessler, A. Dueck, 2012, Journal of Neural Transmission.

Pharmacotherapy in depressed children and adolescents

J. Thome, M. Gerlach, A. Warnke, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.

J. Thome, J. Kornhuber, L. Frölich, 1996, Life sciences.

Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels

J. Thome, A. Coogan, R. Donev, 2012, Molecular Psychiatry.

Time-dependent post-imperative negative variation indicates adaptation and problem solving in migraine patients

J. Thome, P. Kropp, W. Gerber, 2012, Journal of Neural Transmission.

Advanced glycation endproducts in ageing and Alzheimer's disease

J. Thome, P. Riederer, P. Foley, 1997, Brain Research Reviews.

Circadian rhythms and attention deficit hyperactivity disorder: The what, the when and the why

J. Thome, A. Coogan, A. Baird, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[Unexpected Complications in the Withdrawal Treatment of the Research Chemical AH-7921].

D. Rentsch, J. Thome, A. Büttner, 2016, Fortschritte der Neurologie-Psychiatrie.

cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment

J. Thome, D. Storm, R. Duman, 2000, The Journal of Neuroscience.

Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD

J. Thome, F. Faltraco, O. Tucha, 2021, Journal of Neural Transmission.

Combination of Clozapine and Amisulpride in Treatment-Resistant Schizophrenia - Case Reports and Review of the Literature

J. Thome, M. Zink, F. Henn, 2004, Pharmacopsychiatry.

Acute psychosis after injection of pegylated interferon alpha-2a

J. Thome, U. Knopf, 2003, European Psychiatry.

Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials.

J. Thome, E. Doppler, 2012, Drugs of today.

Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

P. Falkai, J. Thome, J. Kornhuber, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

A pilot proteomic study of protein markers in autism spectrum disorder

Costel C. Darie, J. Thome, M. Gerlach, 2014, Electrophoresis.

The potential of biomarkers in psychiatry: focus on proteomics

Costel C. Darie, J. Thome, Izabela Sokolowska, 2015, Journal of Neural Transmission.

Mass spectrometry as a tool for studying autism spectrum disorder

Costel C. Darie, J. Thome, T. Michel, 2013, Journal of molecular psychiatry.

Neuronal death in Alzheimer’s disease and therapeutic opportunities

Rossen Donev, B. Millet, J. Thome, 2009, Journal of cellular and molecular medicine.

Nature and Nurture Predispose to Violent Behavior: Serotonergic Genes and Adverse Childhood Environment

C. Freitag, K. Lesch, J. Thome, 2007, Neuropsychopharmacology.

Neurotrophic factors and the pathophysiology of schizophrenic psychoses

J. Thome, N. Durany, 2004, European Psychiatry.

Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses

J. Thome, P. Riederer, P. Foley, 1998, Journal of Neural Transmission.

Journal of Molecular Psychiatry

J. Thome, 2013, Journal of molecular psychiatry.

Neurogenesis and Beyond – Brain Rejuvenation in Chronic Neurodegenerative and Acute Central Nervous System Diseases

J. Thome, D. Muresanu, 2015 .

A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms

J. Thome, D. Sheer, A. Newall, 2007, Molecular Psychiatry.

Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology

J. Thome, W. Retz, M. Rösler, 2003, Journal of Neural Transmission.

Digit ratio (2D:4D), salivary testosterone, and handedness

J. Thome, A. Beaton, C. Kissling, 2011, Laterality.

Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review

J. Thome, K. Lange, O. Tucha, 2016, Journal of Neural Transmission.

Is ADHD a valid diagnosis in adults? Yes

J. Thome, P. Asherson, M. Adamou, 2010, BMJ : British Medical Journal.

Neuroendocrine support for a relationship between “novelty seeking” and dopaminergic function in alcohol-dependent men

J. Thome, C. Mauerer, G. Wiesbeck, 1995, Psychoneuroendocrinology.

Serum fatty acids, antioxidants, and treatment response in hepatitis C infection: greater polyunsaturated fatty acid and antioxidant levels in hepatitis C responders.

J. Thome, G. Irmisch, E. Reisinger, 2011, Journal of clinical lipidology.

Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism

J. Thome, W. Retz, M. Rösler, 2002, Neuroscience Letters.

Time course of manganese superoxide dismutase concentrations in serum of alcohol-dependent patients during abstinence.

J. Thome, P. Riederer, P. Foley, 1997, Drug and alcohol dependence.

Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder

J. Thome, M. Schecklmann, S. Walitza, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Early View (articles Online in Advance of Print) a Polymorphism at the 3 -untranslated Region of the Clock Gene Is Associated with Adult Attention-deficit Hyperactivity Disorder

C. Freitag, S. Wiemann, J. Thome, 2022 .

Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults

C. Freitag, S. Wiemann, J. Thome, 2007, Journal of Neural Transmission.

[Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist].

J. Thome, R. Stieglitz, W. Retz, 2004, Der Nervenarzt.

The Early Impacts of the COVID-19 Pandemic on Mental Health Facilities and Psychiatric Professionals

J. Thome, W. El-Hage, D. Marazziti, 2021, International journal of environmental research and public health.

Opportunities and Challenges for Professionals in Psychiatry and Mental Health Care Using Digital Technologies During the COVID-19 Pandemic: Systematic Review (Preprint)

J. Thome, W. El-Hage, D. Marazziti, 2021 .

Uses of digital technologies in the time of Covid-19: opportunities and challenges for professionals in psychiatry and mental health care.

J. Thome, D. Marazziti, W. El Hage, 2021, JMIR human factors.

Potential biomarkers in psychiatry: focus on the cholesterol system

Costel C. Darie, J. Thome, M. Gerlach, 2012, Journal of cellular and molecular medicine.

ADHD 24/7: Circadian clock genes, chronotherapy and sleep/wake cycle insufficiencies in ADHD

J. Thome, F. Faltraco, M. Korman, 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine.

J. Thome, C. Mauerer, G. Wiesbeck, 1995, Drug and alcohol dependence.

The role of oxidative stress in depressive disorders.

J. Thome, T. Michel, D. Pülschen, 2012, Current pharmaceutical design.

Mass Spectrometry for Proteomics-Based Investigation of Oxidative Stress and Heat Shock Proteins

Costel C. Darie, J. Thome, Izabela Sokolowska, 2011 .

Discovering a new anatomical structure in the brain: Implications for neuropsychiatry and therapy

M. Barrot, J. Thome, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Influence of acute psychological trauma on time estimation behaviour: a prospective pilot study

J. Thome, F. Petermann, P. Kropp, 2012, Journal of Neural Transmission.

Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia

G. Juckel, J. Thome, M. Brüne, 2015, Journal of Neural Transmission.

Circadian Clocks in the Regulation of Neurotransmitter Systems

J. Thome, F. Faltraco, H. Oster, 2019, Pharmacopsychiatry.

Reply to “CNTF and psychiatric disorders”

J. Thome, J. Kornhuber, P. Riederer, 1996, Nature Genetics.

Variants in neurotrophic factor genes and schizophrenic psychoses: no associations in a Spanish population

J. Thome, P. Riederer, P. Foley, 1997, Psychiatry Research.

Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)—A neurological view

J. Thome, A. Coogan, W. Retz, 2006, European Archives of Psychiatry and Clinical Neuroscience.

Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology.

J. Thome, W. Retz, M. Rösler, 2004, Behavioral sciences & the law.

Evolutionary conservations, changes of circadian rhythms and their effect on circadian disturbances and therapeutic approaches

J. Thome, F. Faltraco, M. Fischer, 2021, Neuroscience & Biobehavioral Reviews.

Differential regulation of synaptic vesicle proteins by antidepressant drugs

J. Thome, C. Jennen-Steinmetz, F. Henn, 2004, The Pharmacogenomics Journal.

CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease

Costel C. Darie, J. Thome, A. G. Woods, 2011, Journal of aging research.

Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis

J. Thome, T. Michel, T. Tatschner, 2004, Journal of Neural Transmission.

Neue Hypothese zur Ätiopathogenese des Alzheimer-Syndroms Advanced glycation endproducts (AGEs)

J. Thome, J. Kornhuber, P. Riederer, 1996, Der Nervenarzt.

[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].

J. Thome, J. Kornhuber, P. Riederer, 1996, Der Nervenarzt.

Haloperidol alters circadian clock gene product expression in the mouse brain

J. Thome, A. Coogan, R. Donev, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The neurobiology of suicide - A Review of post-mortem studies

J. Thome, B. Schutová, T. Michel, 2013, Journal of molecular psychiatry.

Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe

J. Thome, J. Ramos-Quiroga, S. Kraemer, 2015, BMC Psychiatry.

The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies

J. Thome, U. Müller, G. Gudjonsson, 2011, BMC psychiatry.

Availability of psychiatric medication in an urban area of The Gambia/West Africa

J. Thome, J. Höppner, O. Nyan, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Peripheral Biomarker Candidates in Schizophrenia

J. Thome, K. Krysta, A. Bratek, 2014 .

Alcohol withdrawal and dopamine receptor sensitivtty after prolonged abstinence

J. Thome, G. Wiesbeck, N. Wodarz, 1996, Progress in Neuro-psychopharmacology and Biological Psychiatry.

Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients

J. Thome, F. Faltraco, O. Tucha, 2021, Journal of Neural Transmission.

Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease

J. Thome, F. Henn, N. Durany, 2001, Journal of Neural Transmission.

Promoter polymorphism of the 5-HT transporter and Alzheimer's disease

J. Thome, G. Adler, F. Henn, 2000, Neuroscience Letters.

Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.

J. Thome, T. Schwitzer, R. Schwan, 2015, Current pharmaceutical design.

Translational research approach to biological and modifiable risk factors of psychosis and affective disorders

J. Thome, B. Baune, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Inducible and brain region-specific CREB transgenic mice.

M. Kelz, E. Nestler, J. Thome, 2002, Molecular pharmacology.

Proteomics - Biomarkerforschung in der Psychiatrie

J. Thome, J. Grassl, J Thome, 2007, Fortschritte der Neurologie-Psychiatrie.

Free radicals in Alzheimer's dementia: currently available therapeutic strategies.

J. Thome, P. Riederer, W. Retz, 1998, Journal of neural transmission. Supplementum.

Adult attention deficit hyperactivity disorder: translating research into practice

J. Thome, U. Müller, A. Coogan, 2012, ADHD Attention Deficit and Hyperactivity Disorders.

Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder

J. Thome, F. Faltraco, O. Tucha, 2021, Journal of Neural Transmission.

Synchronization of Fibroblasts Ex Vivo in Psychopharmacology

J. Thome, F. Faltraco, D. Palm, 2020, Pharmacopsychiatry.

Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain

M. Barrot, J. Thome, A. Coogan, 2013, Brain Research.

Chronotherapeutics and psychiatry: Setting the clock to relieve the symptoms

Andrew N. Coogan, J. Thome, A. Coogan, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe

J. Thome, F. Faltraco, M. Korman, 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The impact of social jetlag and chronotype on attention, inhibition and decision making in healthy adults

J. Thome, F. Faltraco, A. Coogan, 2020, Journal of sleep research.

Sleep disturbances and circadian CLOCK genes in borderline personality disorder

J. Thome, A. Coogan, F. Hässler, 2012, Journal of Neural Transmission.

Modified magnesium and lipoproteins in children with attention deficite hyperactivity disorder (ADHD)

J. Thome, G. Irmisch, F. Hässler, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Jumping to Conclusions, Liberal Acceptance and the Bias Against Disconfirmatory Evidence: An Evaluation of Reasoning Deviations in Delusions

J. Thome, S. Teipel, 2012 .

Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence

J. Thome, J. Höppner, C. Berger, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Adult attention deficit hyperactivity disorder and other psychiatric symptoms in recreational polydrug users

J. Thome, A. Parrott, R. Donev, 2012, Human psychopharmacology.

Effects of prefrontal rTMS on autonomic reactions to affective pictures

J. Thome, J. Höppner, C. Berger, 2017, Journal of Neural Transmission.

Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect

Eric J. Nestler, Rachael Neve, E. Nestler, 2002, The Journal of Neuroscience.

A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: Interaction with adverse childhood environment

C. Freitag, J. Thome, C. Kissling, 2008, Psychiatry Research.

Association of salivary-assessed oxytocin and cortisol levels with time of night and sleep stage

C. Weidemann, J. Thome, M. Blagrove, 2012, Journal of Neural Transmission.

Detection of feigned attention deficit hyperactivity disorder

J. Thome, A. Fuermaier, J. Koerts, 2015, Journal of Neural Transmission.

Feigning ADHD and stimulant misuse among Dutch university students

J. Thome, F. Faltraco, O. Tucha, 2021, Journal of Neural Transmission.

Sensation seeking, alcoholism and dopamine activity

J. Thome, C. Mauerer, N. Wodarz, 1996, European Psychiatry.

ESCAlate – Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial

A. Fallgatter, J. Thome, T. Banaschewski, 2018, Trials.

Integrating pharmacotherapy and psychotherapy

J. Thome, 2015, Journal of Neural Transmission.

Protein and peptide profiling as a tool for biomarker discovery in depression

J. Thome, R. Donev, E. Dudley, 2012, Electrophoresis.

Pharmacological treatment of adult ADHD in Europe

J. Thome, W. Retz, M. Rösler, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Mass spectrometry for the detection of potential psychiatric biomarkers

J. Thome, T. Michel, Izabela Sokolowska, 2013, Journal of molecular psychiatry.

Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial

Jutta S. Mayer, C. Freitag, U. Ebner-Priemer, 2018, Trials.

Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine

J. Thome, L. Greenhill, A. Heinloth, 2017, ADHD Attention Deficit and Hyperactivity Disorders.

Agomelatine: an agent against anhedonia and abulia?

J. Thome, P. Foley, Johannes Thome, 2015, Journal of Neural Transmission.

Insomnia complaints and substance use in German adolescents: did we underestimate the role of coffee consumption? Results of the KiGGS study

J. Thome, S. Cohrs, B. Szagun, 2017, Journal of Neural Transmission.

Genome polymorphism and alcoholism.

J. Gewirtz, J. Thome, F. Henn, 2000, Pharmacogenomics.

Psychiatry and Preclinical Psychiatric Studies -original Article Sustained Attention in Adult Adhd: Time-on-task Effects of Various Measures of Attention

J. Thome, K. Lange, O. Tucha, 2022 .

Short communication Attention deficit hyperactivity disorder (ADHD) in a 19th century children's book

J. Thome, 2004 .

Blink rate and blink timing in children with ADHD and the influence of stimulant medication

J. Thome, O. Tucha, N. Börger, 2015, Journal of Neural Transmission.

Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses

J. Thome, M. Zink, F. Henn, 2004, European Psychiatry.

Prevalence of attention deficit–/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates*

J. Thome, P. Wender, M. Schneider, 2004, European Archives of Psychiatry and Clinical Neuroscience.

Characterisation of different nanoparticles with a potential use for drug delivery in neuropsychiatric disorders

J. Thome, P. Petrov, R. Donev, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder

J. Thome, F. Faltraco, O. Tucha, 2021, Journal of Neural Transmission.

How does healthy aging impact on the circadian clock?

J. Thome, A. Coogan, A. Popa-Wagner, 2017, Journal of Neural Transmission.

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD)

P. Falkai, J. Thome, R. Stieglitz, 2006, European Archives of Psychiatry and Clinical Neuroscience.

Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry

J. Thome, M. Gerlach, A. Warnke, 2010, European Archives of Psychiatry and Clinical Neuroscience.

Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder

J. Thome, M. Schecklmann, S. Walitza, 2014, Journal of Neural Transmission.

Cyclic AMP response element-binding protein and depression

J. Thome, R. Duman, F. Henn, 2002, Expert review of neurotherapeutics.

A comparison of gEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer’s disease

T. Dierks, A. Fallgatter, W. Strik, 2008, European Archives of Psychiatry and Clinical Neuroscience.

Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology.

J. Thome, P. Riederer, N. Durany, 2000, Journal of Alzheimer's disease : JAD.

Adult ADHD and suicide

J. Thome, K. Furczyk, 2014, ADHD Attention Deficit and Hyperactivity Disorders.

Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissue.

J. Thome, P. Riederer, T. Michel, 1997, Journal fur Hirnforschung.

[Symptoms from the spectrum of Attention-Deficit/Hyperactivity Disorder (ADHD) in sexual delinquents].

J. Thome, W. Retz, M. Rösler, 2001, Fortschritte der Neurologie-Psychiatrie.

Psychometric Properties of the Romanian Version of the Composite Scale of Morningness in Healthy Adults

J. Thome, A. Coogan, B. Voinescu, 2010 .

Upregulation of Galanin Binding Sites and GalR1 mRNA Levels in the Mouse Locus Coeruleus Following Chronic Morphine Treatments and Precipitated Morphine Withdrawal

J. Thome, M. Picciotto, V. Zachariou, 2000, Neuropsychopharmacology.

Comorbidity of schizophrenia and adult attention-deficit hyperactivity disorder

A. Meyer-Lindenberg, J. Thome, R. Donev, 2011, World Journal of Biological Psychiatry.

Structural and functional cortical disconnection in Alzheimer's disease: A combined study using diffusion tensor imaging and transcranial magnetic stimulation

J. Thome, S. Teipel, Karlheinz Hauenstein, 2013, Psychiatry Research: Neuroimaging.

EUDOR-A multi-centre research program: A naturalistic, European Multi-centre Clinical study of EDOR Test in adult patients with primary depression

E. Baca-García, P. Courtet, A. Batra, 2017, BMC Psychiatry.

Reduced expression of complexins I and II in rats bred for learned helplessness

J. Thome, P. Gebicke-haerter, B. Vollmayr, 2007, Brain Research.

Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population

G. Sedvall, J. Thome, P. Riederer, 1997, Psychiatric genetics.

Diagnostic characteristics of inpatients in a Western African psychiatric hospital

J. Thome, O. Nyan, C. Berger, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia

J. Thome, M. Gerlach, R. Taurines, 2010, European Child & Adolescent Psychiatry.

The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry

J. Thome, D. Palm, 2023, Pharmacopsychiatry.

Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD

J. Thome, G. Irmisch, A. Sheldrick, 2013, ADHD Attention Deficit and Hyperactivity Disorders.

Intra- and inter-cortical motor excitability in Alzheimer’s disease

J. Thome, S. Teipel, Martin Wegrzyn, 2012, Journal of Neural Transmission.

EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)

C. Freitag, A. Fallgatter, T. Ethofer, 2021, Brain sciences.

The rs1801260 CLOCK polymorphism, links to depression, insomnia and diurnal preference - preliminary findings from a Romanian sample.

J. Thome, B. Voinescu, R. Orăsan, 2009 .

Left hemispheric reductions of regional cerebral blood flow (rCBF) correlate with measures of dementia severity in patients with Alzheimer's disease: a SPECT study

J. Thome, L. Frölich, K. Maurer, 1996, European Psychiatry.

CNTF AND PSYCHIATRIC DISORDERS. AUTHORS' REPLY

S. Cichon, Tao Li, M. Rietschel, 1996 .

Molecular Link between Circadian Rhythmicity and Mood Disorders.

J. Thome, F. Faltraco, O. Tucha, 2021, Current Medicinal Chemistry.

Apolipoprotein E-ε4 allele frequency in late-onset depression

J. Thome, A. Heidrich, M. Rösler, 1997, Biological Psychiatry.

Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractory auditory hallucinations and major self-mutilation

J. Thome, B. Krause, C. Berger, 2015, Journal of Neural Transmission.

Risperidone-induced priapism

J. Thome, Devendra Makesar, 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Interdisciplinary approaches for the understanding of neuropsychiatric disorders

J. Thome, P. Riederer, K. Double, 2002, Journal of Neural Transmission.

[Zolpidem dependence and depression in the elderly].

J. Thome, M. Ruchsow, M. Rösler, 1995, Psychiatrische Praxis.

Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating.

J. Thome, P. Riederer, G. Wiesbeck, 1999, Psychiatric genetics.

The Impact of Methylphenidate on Circadian Rhythms and Clock Gene Expression

J. Thome, A. Coogan, A. Baird, 2016 .

Centenary of Karl Jaspers’s general psychopathology: implications for molecular psychiatry

J. Thome, 2014, Journal of molecular psychiatry.

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: Effect of different processing and analysis approaches on sample sizes

F. Jessen, W. Maier, I. Heuser, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Are non-demented patients with Parkinson's disease able to decide about their own treatment?

J. Thome, O. Tucha, A. Fuermaier, 2017, Parkinsonism & related disorders.

University of Groningen Are non-demented patients with Parkinson's disease able to decide about their own treatment? Eygelshoven,

J. Thome, O. Tucha, J. Koerts, 2017 .

Resting state fMRI entropy probes complexity of brain activity in adults with ADHD

Moses O. Sokunbi, D. Linden, J. Thome, 2013, Psychiatry Research: Neuroimaging.

Cyclic AMP response element-binding protein and depression

J. Thome, R. Duman, F. Henn, 2002, Expert review of neurotherapeutics.

Modern neuroimaging in psychiatry: Towards the integration of functional and molecular information

D. Linden, J. Thome, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Neurotrophic factor‐related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high‐risk male population

R. M. Clement, C. Freitag, J. Thome, 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Is ADHD a valid diagnosis in adults? No

J. Thome, P. Asherson, M. Adamou, 2010, BMJ : British Medical Journal.

The impact of the COVID-19 outbreak on the medico-legal and human rights of psychiatric patients

J. Thome, F. Faltraco, O. Tucha, 2020, European Psychiatry.